Loading provider…
Loading provider…
Gastroenterology Physician in Flushing, NY
NPI: 1225053523Primary Practice Location
Royal Medical Endoscopy PLLC
142-41 41st Ave, Flushing, NY
Primary Employer
Dreamwork Medical, PLLC
HQ Phone
Get M.D. Sing's Phone Numberphone_androidMobile
Get M.D. Sing's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1993 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Gastroenterology
New York Medical College at St Vincent's Hospital and Medical Center of New York
Fellowship • Gastroenterology
1995 - 1997
SUNY Downstate Health Sciences University
downstate.edu
Medical School
Until 1991
NYU Grossman School of Medicine (Veterans)
Residency • Internal Medicine
1991 - 1994
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 145 | 242 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 144 | 145 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 95 | 124 |
| 4 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | 69 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 61 | 61 |
Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings.
Authors: Alan Yao, Huy Trinh, Calvin Pan
Publication Date: 2013-09-24
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: OTHER: Blood Sample Collection
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: DIAGNOSTIC_TEST: FIT test, PROCEDURE: Colonoscopy, DIAGNOSTIC_TEST: mt-sDNA 2.0 screening test
Lead Sponsor: Target PharmaSolutions, Inc.
Intervention / Treatment: OTHER: All approved therapies for the treatment of Chronic Hepatitis B (CHB)